Since 2020, the ISOLDA consortium has been collaborating to develop improved vaccines against viral infections for older adults. The collaboration has resulted in a number of peer-reviewed articles in academic journals. Over the coming months, we will share these articles in the News section of our website. Today, the consortium is proud to present the...Read More
The EU Research and Innovation programme HORIZON 2020 has awarded a contract to the ISOLDA consortium, led by Stiftung Tieraerztliche Hochschule Hannover (TiHo), to develop improved vaccines against viral infections for older adults. The average age of citizens of the European Union (EU) is increasing, with currently 20% aged over 65. Ageing is one of...Read More
In the ISOLDA project, seven consortium partners work together in the development of improved vaccines against viral diseases with highest burdens at old age.